UK markets closed
NIKKEI 225
38,202.37 -632.73 (-1.63%) HANG SENG
18,313.86 -165.51 (-0.90%) CRUDE OIL
79.21 +0.83 (+1.06%) GOLD FUTURES
2,316.30 -7.90 (-0.34%) DOW
39,056.39 +172.13 (+0.44%) Bitcoin GBP
49,535.15 -1,000.84 (-1.98%)
Quest Diagnostics Inc (QDI.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
At close: 08:10AM CEST
| Previous close | 125.35 |
| Open | 126.75 |
| Bid | 126.60 x 0 |
| Ask | 126.90 x 0 |
| Day's range | 126.75 - 126.75 |
| 52-week range | 113.25 - 131.35 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
- Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
- Zacks
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
© 2024 Yahoo. All rights reserved.